Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients

NCT02412982 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

103

Enrollment

OTHER

Sponsor class

Conditions

Traumatic Injury
Venous Thromboembolism

Interventions

DRUG: Enoxaparin 40 mg q12h
DRUG: Enoxaparin 30 mg q8h

Sponsor

University of Cincinnati

Collaborators

[object Object]